2022
DOI: 10.1016/j.diii.2022.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Serous cystadenoma mimicking cystic pancreatic neuroendocrine tumor on 68Ga-DOTATOC PET/CT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 5 publications
1
1
0
Order By: Relevance
“…This indicates that PET/CT is helpful in the diagnosis of pancreatic neuroendocrine tumor when tumor uptake of 68 Ga-DOTA somatostatin analogs is observed. But false-positive results can also occur, as demonstrated by serous cystadenoma of the pancreas with 68 Ga-DOTATOC PET/CT uptake, as reported previously 5–7 . The current case showed that a pancreatic serous cystadenoma may display moderate 68 Ga-DOTATATE uptake at the edge of the lesion on PET/MRI.…”
supporting
confidence: 78%
See 1 more Smart Citation
“…This indicates that PET/CT is helpful in the diagnosis of pancreatic neuroendocrine tumor when tumor uptake of 68 Ga-DOTA somatostatin analogs is observed. But false-positive results can also occur, as demonstrated by serous cystadenoma of the pancreas with 68 Ga-DOTATOC PET/CT uptake, as reported previously 5–7 . The current case showed that a pancreatic serous cystadenoma may display moderate 68 Ga-DOTATATE uptake at the edge of the lesion on PET/MRI.…”
supporting
confidence: 78%
“…But false-positive results can also occur, as demonstrated by serous cystadenoma of the pancreas with 68 Ga-DOTATOC PET/CT uptake, as reported previously. [5][6][7] The current case showed that a pancreatic serous cystadenoma may display moderate 68 Ga-DOTATATE uptake at the edge of the lesion on PET/MRI. The superior soft-tissue resolution of MRI is able to reveal the high fluid content of serous cystadenoma, especially in DWI.…”
mentioning
confidence: 58%